You have 9 free searches left this month | for more free features.

Follicular lymphoma (FL)

Showing 51 - 75 of 6,170

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Recurrent Follicular Lymphoma, Refractory Follicular Lymphoma Trial in Duarte (Tazemetostat, Ublituximab, Umbralisib)

Not yet recruiting
  • Recurrent Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Duarte, California
    City of Hope Medical Center
Jul 31, 2022

Lymphoma Trial in Houston (Rituximab, Lenalidomide, Valemetostat)

Not yet recruiting
  • Lymphoma
  • Houston, Texas
    M D Anderson Cancer Center
Jan 4, 2023

Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

Not yet recruiting
  • Follicular Lymphoma
  • +3 more
  • Tazemetostat Pill
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Jun 28, 2023

Relapsed/Refractory Follicular Lymphoma Trial in Nashville (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine)

Recruiting
  • Relapsed/Refractory Follicular Lymphoma
  • Axicabtagene Ciloleucel
  • +8 more
  • Denver, Colorado
  • +6 more
Dec 2, 2022

Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Birmingham (Carevive CarePlanning System)

Completed
  • Diffuse Large B Cell Lymphoma
  • Follicular Lymphoma
  • Carevive CarePlanning System
  • Birmingham, Alabama
    University of Alabama Birmingham
Dec 10, 2020

Patients Undergoing Follicular Lymphoma Clinical Research

Not yet recruiting
  • Follicular Lymphoma
    • San Francisco, California
      Power Life Sciences
    Sep 15, 2023

    Follicular Lymphoma Trial in Boston (Rituximab, Neo Vax, Pembrolizumab)

    Recruiting
    • Follicular Lymphoma
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Mar 14, 2022

    Follicular Lymphoma, Marginal Zone Lymphoma, Mantle Cell Lymphoma Trial run by the NCI (Obinutuzumab, Venetoclax, Magrolimab)

    Recruiting
    • Follicular Lymphoma
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Follicular Lymphoma Trial in United States (DRL_RI (Proposed rituximab biosimilar), MabThera®)

    Active, not recruiting
    • Follicular Lymphoma
    • DRL_RI (Proposed rituximab biosimilar)
    • MabThera®
    • Whittier, California
    • +3 more
    May 27, 2022

    Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma, Recurrent Grade 2 Follicular Lymphoma Trial in Houston (other, drug,

    Recruiting
    • Recurrent Diffuse Large B-Cell Lymphoma
    • +3 more
    • Laboratory Biomarker Analysis
    • +3 more
    • Houston, Texas
      M D Anderson Cancer Center
    Jul 26, 2022

    Living Conditions of Diffuse Large B-Cell Lymphoma or Follicular

    Completed
    • Diffuse Large Cell Diffuse Lymphoma
    • Follicular Lymphoma
    • Questionnaires
    • Collection of clinical data and treatments
    • Dijon, France
      Chu Dijon Bourogne
    Jan 31, 2023

    Relapsed/Refractory Follicular Lymphoma With EZH2 Trial in Shanghai (Tazemetostat)

    Not yet recruiting
    • Relapsed/Refractory Follicular Lymphoma With EZH2
    • Shanghai, Shanghai, China
      Shanghai Cancer Center
    Jul 20, 2022

    Follicular Lymphoma Trial (Axicabtagene Ciloleucel, Cyclophosphamide, Fludarabine phosphate)

    Not yet recruiting
    • Follicular Lymphoma
    • Axicabtagene Ciloleucel
    • +5 more
    • (no location specified)
    Sep 21, 2023

    (CHANT)Real World Study of Duvelisib in Treatment of

    Not yet recruiting
    • Follicular Lymphoma
    • +5 more
    • (no location specified)
    Jun 20, 2023

    Adult Patients Who Initiate Systemic Treatment for Relapsed or

    Recruiting
    • Relapsed/Refractory Follicular Lymphoma
    • Non-Interventional
    • Graz, Austria
    • +8 more
    Sep 19, 2022

    COVID-19 Vaccine and Other Vaccines'-Induced Immune Responses in

    Not yet recruiting
    • Follicular Lymphoma
    • Cellular immunity vs SARS-CoV-2
    • +6 more
    • Alessandria, IT, Italy
    • +13 more
    Oct 10, 2023

    Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)

    Not yet recruiting
    • Follicular Lymphoma
    • New York, New York
      Weill Cornell Medicine/NewYork-Presbyterian Hospital
    Aug 8, 2023

    Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Follicular Lymphoma, Recurrent Indolent Adult Non-Hodgkin Lymphoma Trial in

    Suspended
    • Recurrent B-Cell Non-Hodgkin Lymphoma
    • +7 more
    • Philadelphia, Pennsylvania
      Sidney Kimmel Cancer Center at Thomas Jefferson University
    Jan 20, 2023

    Marginal Zone Lymphoma, Follicular Lymphoma Trial in Aurora (Ublituximab, Umbralisib)

    Suspended
    • Marginal Zone Lymphoma
    • Follicular Lymphoma
    • Aurora, Colorado
      University of Colorado Hospital
    Feb 22, 2022

    Ann Arbor Stage II Grade 1 Follicular Lymphoma, Ann Arbor Stage II Grade 2 Follicular Lymphoma, Ann Arbor Stage III Grade 1

    Active, not recruiting
    • Ann Arbor Stage II Grade 1 Follicular Lymphoma
    • +12 more
    • Houston, Texas
      M D Anderson Cancer Center
    Feb 18, 2022

    Follicular Lymphoma, Refractory Follicular Lymphoma Trial (Tazverik (Tazemetostat))

    Not yet recruiting
    • Follicular Lymphoma
    • Refractory Follicular Lymphoma
    • Tazverik (Tazemetostat)
    • (no location specified)
    Oct 6, 2023

    Follicular Lymphoma, Lymphoma Trial in United States (Mosunetuzumab)

    Recruiting
    • Follicular Lymphoma
    • Lymphoma
    • Basking Ridge, New Jersey
    • +6 more
    Nov 9, 2022

    Follicular Lymphoma, Endometrial Cancer Trial in New York (Copanlisib, Ketogenic Diet)

    Recruiting
    • Follicular Lymphoma
    • Endometrial Cancer
    • New York, New York
    • +2 more
    Nov 24, 2021